
Global Biopharmaceuticals Contract Manufacturing Service Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Biopharmaceuticals Contract Manufacturing Service market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Biopharmaceuticals Contract Manufacturing Service market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Biopharmaceuticals Contract Manufacturing Service market include WuXi Biologics, Takeda, Sanofi, Johnson & Johnson, Merck, Roche, Lonza Group, Pfizer and GlaxoSmithKline, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Biopharmaceuticals Contract Manufacturing Service, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Biopharmaceuticals Contract Manufacturing Service, also provides the value of main regions and countries. Of the upcoming market potential for Biopharmaceuticals Contract Manufacturing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biopharmaceuticals Contract Manufacturing Service revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Biopharmaceuticals Contract Manufacturing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Biopharmaceuticals Contract Manufacturing Service company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Biopharmaceuticals Contract Manufacturing Service Segment by Company
WuXi Biologics
Takeda
Sanofi
Johnson & Johnson
Merck
Roche
Lonza Group
Pfizer
GlaxoSmithKline
AbbVie
Samsung BioLogics
Rentschler Biotechnologie
ProBioGen
Novo Medi Sciences
JRS Pharma
Galentic Pharma
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
AGC Biologics
Biopharmaceuticals Contract Manufacturing Service Segment by Type
Packaging
Process Development
Manufacturing
Biopharmaceuticals Contract Manufacturing Service Segment by Application
Vaccines
Peptides and Protein
Biosimilars
Antibodies
Others
Biopharmaceuticals Contract Manufacturing Service Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Biopharmaceuticals Contract Manufacturing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Biopharmaceuticals Contract Manufacturing Service key companies, revenue, market share, and recent developments.
3. To split the Biopharmaceuticals Contract Manufacturing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Biopharmaceuticals Contract Manufacturing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biopharmaceuticals Contract Manufacturing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Biopharmaceuticals Contract Manufacturing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals Contract Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals Contract Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals Contract Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceuticals Contract Manufacturing Service industry.
Chapter 3: Detailed analysis of Biopharmaceuticals Contract Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Biopharmaceuticals Contract Manufacturing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Biopharmaceuticals Contract Manufacturing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
According to APO Research, the global Biopharmaceuticals Contract Manufacturing Service market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.
The Asia-Pacific market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Biopharmaceuticals Contract Manufacturing Service market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.
The Europe market for Biopharmaceuticals Contract Manufacturing Service is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Biopharmaceuticals Contract Manufacturing Service market include WuXi Biologics, Takeda, Sanofi, Johnson & Johnson, Merck, Roche, Lonza Group, Pfizer and GlaxoSmithKline, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.
This report presents an overview of global market for Biopharmaceuticals Contract Manufacturing Service, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Biopharmaceuticals Contract Manufacturing Service, also provides the value of main regions and countries. Of the upcoming market potential for Biopharmaceuticals Contract Manufacturing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Biopharmaceuticals Contract Manufacturing Service revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Biopharmaceuticals Contract Manufacturing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Biopharmaceuticals Contract Manufacturing Service company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Biopharmaceuticals Contract Manufacturing Service Segment by Company
WuXi Biologics
Takeda
Sanofi
Johnson & Johnson
Merck
Roche
Lonza Group
Pfizer
GlaxoSmithKline
AbbVie
Samsung BioLogics
Rentschler Biotechnologie
ProBioGen
Novo Medi Sciences
JRS Pharma
Galentic Pharma
FUJIFILM Diosynth Biotechnologies
Boehringer Ingelheim
AGC Biologics
Biopharmaceuticals Contract Manufacturing Service Segment by Type
Packaging
Process Development
Manufacturing
Biopharmaceuticals Contract Manufacturing Service Segment by Application
Vaccines
Peptides and Protein
Biosimilars
Antibodies
Others
Biopharmaceuticals Contract Manufacturing Service Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Biopharmaceuticals Contract Manufacturing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Biopharmaceuticals Contract Manufacturing Service key companies, revenue, market share, and recent developments.
3. To split the Biopharmaceuticals Contract Manufacturing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Biopharmaceuticals Contract Manufacturing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biopharmaceuticals Contract Manufacturing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Biopharmaceuticals Contract Manufacturing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceuticals Contract Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceuticals Contract Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceuticals Contract Manufacturing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biopharmaceuticals Contract Manufacturing Service industry.
Chapter 3: Detailed analysis of Biopharmaceuticals Contract Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Biopharmaceuticals Contract Manufacturing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Biopharmaceuticals Contract Manufacturing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Table of Contents
203 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biopharmaceuticals Contract Manufacturing Service Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Biopharmaceuticals Contract Manufacturing Service Market Size (2020-2031)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Biopharmaceuticals Contract Manufacturing Service Market Dynamics
- 2.1 Biopharmaceuticals Contract Manufacturing Service Industry Trends
- 2.2 Biopharmaceuticals Contract Manufacturing Service Industry Drivers
- 2.3 Biopharmaceuticals Contract Manufacturing Service Industry Opportunities and Challenges
- 2.4 Biopharmaceuticals Contract Manufacturing Service Industry Restraints
- 3 Biopharmaceuticals Contract Manufacturing Service Market by Company
- 3.1 Global Biopharmaceuticals Contract Manufacturing Service Company Revenue Ranking in 2024
- 3.2 Global Biopharmaceuticals Contract Manufacturing Service Revenue by Company (2020-2025)
- 3.3 Global Biopharmaceuticals Contract Manufacturing Service Company Ranking (2023-2025)
- 3.4 Global Biopharmaceuticals Contract Manufacturing Service Company Manufacturing Base and Headquarters
- 3.5 Global Biopharmaceuticals Contract Manufacturing Service Company Product Type and Application
- 3.6 Global Biopharmaceuticals Contract Manufacturing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Biopharmaceuticals Contract Manufacturing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.7.3 2024 Biopharmaceuticals Contract Manufacturing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
- 4 Biopharmaceuticals Contract Manufacturing Service Market by Type
- 4.1 Biopharmaceuticals Contract Manufacturing Service Type Introduction
- 4.1.1 Packaging
- 4.1.2 Process Development
- 4.1.3 Manufacturing
- 4.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Type
- 4.2.1 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Type (2020-2031)
- 4.2.3 Global Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type (2020-2031)
- 5 Biopharmaceuticals Contract Manufacturing Service Market by Application
- 5.1 Biopharmaceuticals Contract Manufacturing Service Application Introduction
- 5.1.1 Vaccines
- 5.1.2 Peptides and Protein
- 5.1.3 Biosimilars
- 5.1.4 Antibodies
- 5.1.5 Others
- 5.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Application
- 5.2.1 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Application (2020-2031)
- 5.2.3 Global Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application (2020-2031)
- 6 Biopharmaceuticals Contract Manufacturing Service Regional Value Analysis
- 6.1 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Region: 2020 VS 2024 VS 2031
- 6.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Region (2020-2031)
- 6.2.1 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Region: 2020-2025
- 6.2.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Region (2026-2031)
- 6.3 North America
- 6.3.1 North America Biopharmaceuticals Contract Manufacturing Service Sales Value (2020-2031)
- 6.3.2 North America Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Country, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Biopharmaceuticals Contract Manufacturing Service Sales Value (2020-2031)
- 6.4.2 Europe Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Country, 2024 VS 2031
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Sales Value (2020-2031)
- 6.5.2 Asia-Pacific Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Country, 2024 VS 2031
- 6.6 South America
- 6.6.1 South America Biopharmaceuticals Contract Manufacturing Service Sales Value (2020-2031)
- 6.6.2 South America Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Country, 2024 VS 2031
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Sales Value (2020-2031)
- 6.7.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Country, 2024 VS 2031
- 7 Biopharmaceuticals Contract Manufacturing Service Country-level Value Analysis
- 7.1 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Country: 2020 VS 2024 VS 2031
- 7.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Country (2020-2031)
- 7.2.1 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Country (2020-2025)
- 7.2.2 Global Biopharmaceuticals Contract Manufacturing Service Sales Value by Country (2026-2031)
- 7.3 USA
- 7.3.1 USA Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.3.2 USA Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.3.3 USA Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.4 Canada
- 7.4.1 Canada Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.4.2 Canada Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.4.3 Canada Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.5 Mexico
- 7.5.1 Mexico Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.5.2 Mexico Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.5.3 Mexico Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.6 Germany
- 7.6.1 Germany Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.6.2 Germany Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Germany Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.7 France
- 7.7.1 France Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.7.2 France Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.7.3 France Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.8 U.K.
- 7.8.1 U.K. Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.8.2 U.K. Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.8.3 U.K. Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.9 Italy
- 7.9.1 Italy Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.9.2 Italy Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.9.3 Italy Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.10 Spain
- 7.10.1 Spain Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.10.2 Spain Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.10.3 Spain Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.11 Russia
- 7.11.1 Russia Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.11.2 Russia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Russia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.12 Netherlands
- 7.12.1 Netherlands Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.12.2 Netherlands Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Netherlands Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.13.2 Nordic Countries Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Nordic Countries Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.14 China
- 7.14.1 China Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.14.2 China Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.14.3 China Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.15 Japan
- 7.15.1 Japan Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.15.2 Japan Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Japan Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.16 South Korea
- 7.16.1 South Korea Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.16.2 South Korea Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.16.3 South Korea Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.17 India
- 7.17.1 India Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.17.2 India Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.17.3 India Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.18 Australia
- 7.18.1 Australia Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.18.2 Australia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.18.3 Australia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.19.2 Southeast Asia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.19.3 Southeast Asia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.20 Brazil
- 7.20.1 Brazil Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.20.2 Brazil Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Brazil Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.21 Argentina
- 7.21.1 Argentina Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.21.2 Argentina Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Argentina Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.22 Chile
- 7.22.1 Chile Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.22.2 Chile Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Chile Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.23 Colombia
- 7.23.1 Colombia Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.23.2 Colombia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Colombia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.24 Peru
- 7.24.1 Peru Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.24.2 Peru Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Peru Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.25.2 Saudi Arabia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Saudi Arabia Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.26 Israel
- 7.26.1 Israel Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.26.2 Israel Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Israel Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.27 UAE
- 7.27.1 UAE Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.27.2 UAE Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.27.3 UAE Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.28 Turkey
- 7.28.1 Turkey Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.28.2 Turkey Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Turkey Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.29 Iran
- 7.29.1 Iran Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.29.2 Iran Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.29.3 Iran Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 7.30 Egypt
- 7.30.1 Egypt Biopharmaceuticals Contract Manufacturing Service Sales Value Growth Rate (2020-2031)
- 7.30.2 Egypt Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Egypt Biopharmaceuticals Contract Manufacturing Service Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 WuXi Biologics
- 8.1.1 WuXi Biologics Comapny Information
- 8.1.2 WuXi Biologics Business Overview
- 8.1.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.1.4 WuXi Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.1.5 WuXi Biologics Recent Developments
- 8.2 Takeda
- 8.2.1 Takeda Comapny Information
- 8.2.2 Takeda Business Overview
- 8.2.3 Takeda Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.2.4 Takeda Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.2.5 Takeda Recent Developments
- 8.3 Sanofi
- 8.3.1 Sanofi Comapny Information
- 8.3.2 Sanofi Business Overview
- 8.3.3 Sanofi Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.3.4 Sanofi Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.3.5 Sanofi Recent Developments
- 8.4 Johnson & Johnson
- 8.4.1 Johnson & Johnson Comapny Information
- 8.4.2 Johnson & Johnson Business Overview
- 8.4.3 Johnson & Johnson Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.4.4 Johnson & Johnson Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.4.5 Johnson & Johnson Recent Developments
- 8.5 Merck
- 8.5.1 Merck Comapny Information
- 8.5.2 Merck Business Overview
- 8.5.3 Merck Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.5.4 Merck Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.5.5 Merck Recent Developments
- 8.6 Roche
- 8.6.1 Roche Comapny Information
- 8.6.2 Roche Business Overview
- 8.6.3 Roche Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.6.4 Roche Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.6.5 Roche Recent Developments
- 8.7 Lonza Group
- 8.7.1 Lonza Group Comapny Information
- 8.7.2 Lonza Group Business Overview
- 8.7.3 Lonza Group Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.7.4 Lonza Group Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.7.5 Lonza Group Recent Developments
- 8.8 Pfizer
- 8.8.1 Pfizer Comapny Information
- 8.8.2 Pfizer Business Overview
- 8.8.3 Pfizer Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.8.4 Pfizer Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.8.5 Pfizer Recent Developments
- 8.9 GlaxoSmithKline
- 8.9.1 GlaxoSmithKline Comapny Information
- 8.9.2 GlaxoSmithKline Business Overview
- 8.9.3 GlaxoSmithKline Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.9.4 GlaxoSmithKline Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.9.5 GlaxoSmithKline Recent Developments
- 8.10 AbbVie
- 8.10.1 AbbVie Comapny Information
- 8.10.2 AbbVie Business Overview
- 8.10.3 AbbVie Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.10.4 AbbVie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.10.5 AbbVie Recent Developments
- 8.11 Samsung BioLogics
- 8.11.1 Samsung BioLogics Comapny Information
- 8.11.2 Samsung BioLogics Business Overview
- 8.11.3 Samsung BioLogics Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.11.4 Samsung BioLogics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.11.5 Samsung BioLogics Recent Developments
- 8.12 Rentschler Biotechnologie
- 8.12.1 Rentschler Biotechnologie Comapny Information
- 8.12.2 Rentschler Biotechnologie Business Overview
- 8.12.3 Rentschler Biotechnologie Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.12.4 Rentschler Biotechnologie Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.12.5 Rentschler Biotechnologie Recent Developments
- 8.13 ProBioGen
- 8.13.1 ProBioGen Comapny Information
- 8.13.2 ProBioGen Business Overview
- 8.13.3 ProBioGen Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.13.4 ProBioGen Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.13.5 ProBioGen Recent Developments
- 8.14 Novo Medi Sciences
- 8.14.1 Novo Medi Sciences Comapny Information
- 8.14.2 Novo Medi Sciences Business Overview
- 8.14.3 Novo Medi Sciences Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.14.4 Novo Medi Sciences Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.14.5 Novo Medi Sciences Recent Developments
- 8.15 JRS Pharma
- 8.15.1 JRS Pharma Comapny Information
- 8.15.2 JRS Pharma Business Overview
- 8.15.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.15.4 JRS Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.15.5 JRS Pharma Recent Developments
- 8.16 Galentic Pharma
- 8.16.1 Galentic Pharma Comapny Information
- 8.16.2 Galentic Pharma Business Overview
- 8.16.3 Galentic Pharma Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.16.4 Galentic Pharma Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.16.5 Galentic Pharma Recent Developments
- 8.17 FUJIFILM Diosynth Biotechnologies
- 8.17.1 FUJIFILM Diosynth Biotechnologies Comapny Information
- 8.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 8.17.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.17.4 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.17.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 8.18 Boehringer Ingelheim
- 8.18.1 Boehringer Ingelheim Comapny Information
- 8.18.2 Boehringer Ingelheim Business Overview
- 8.18.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.18.4 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.18.5 Boehringer Ingelheim Recent Developments
- 8.19 AGC Biologics
- 8.19.1 AGC Biologics Comapny Information
- 8.19.2 AGC Biologics Business Overview
- 8.19.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Service Revenue and Gross Margin (2020-2025)
- 8.19.4 AGC Biologics Biopharmaceuticals Contract Manufacturing Service Product Portfolio
- 8.19.5 AGC Biologics Recent Developments
- 9 Concluding Insights
- 10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.